89 related articles for article (PubMed ID: 22503877)
41. Sex steroids concentrations in relation to bone mineral density in men with coronary atherosclerosis.
Dunajska K; Milewicz A; Jóźków P; Jedrzejuk D; Kuliczkowski W; Lwow F
Maturitas; 2006 Sep; 55(2):142-9. PubMed ID: 16503102
[TBL] [Abstract][Full Text] [Related]
42. Identification of serum metabolites associated with obesity and traditional risk factors for metabolic disease in Chinese adults.
Wang SM; Yang RY; Wang M; Ji FS; Li HX; Tang YM; Chen WX; Dong J
Nutr Metab Cardiovasc Dis; 2018 Feb; 28(2):112-118. PubMed ID: 29122443
[TBL] [Abstract][Full Text] [Related]
43. Interleukin-22 Might Act as a Double-Edged Sword in Type 2 Diabetes and Coronary Artery Disease.
Gong F; Wu J; Zhou P; Zhang M; Liu J; Liu Y; Lu X; Liu Z
Mediators Inflamm; 2016; 2016():8254797. PubMed ID: 27829708
[TBL] [Abstract][Full Text] [Related]
44. Metabolism and atherogenic disease association of lysophosphatidylcholine.
Schmitz G; Ruebsaamen K
Atherosclerosis; 2010 Jan; 208(1):10-8. PubMed ID: 19570538
[TBL] [Abstract][Full Text] [Related]
45. Probing gender-specific lipid metabolites and diagnostic biomarkers for lung cancer using Fourier transform ion cyclotron resonance mass spectrometry.
Guo Y; Wang X; Qiu L; Qin X; Liu H; Wang Y; Li F; Wang X; Chen G; Song G; Li F; Guo S; Li Z
Clin Chim Acta; 2012 Dec; 414():135-41. PubMed ID: 22906735
[TBL] [Abstract][Full Text] [Related]
46. Increased lysophosphatidic acid levels in culprit coronary arteries of patients with acute coronary syndrome.
Dohi T; Miyauchi K; Ohkawa R; Nakamura K; Kurano M; Kishimoto T; Yanagisawa N; Ogita M; Miyazaki T; Nishino A; Yaginuma K; Tamura H; Kojima T; Yokoyama K; Kurata T; Shimada K; Daida H; Yatomi Y
Atherosclerosis; 2013 Jul; 229(1):192-7. PubMed ID: 23664202
[TBL] [Abstract][Full Text] [Related]
47. Elevated serum glycosaminoglycans with hypomagnesemia in patients with coronary artery disease & thrombotic stroke.
Kumari KT; Augustine J; Leelamma S; Kurup PA; Ravikumar A; Sajeesh K; Eapen S; Nair AR; Vijayalekshmi N; Karthikeyan S
Indian J Med Res; 1995 Mar; 101():115-9. PubMed ID: 7751039
[TBL] [Abstract][Full Text] [Related]
48. A Non-Targeted Liquid Chromatographic-Mass Spectrometric Metabolomics Approach for Association with Coronary Artery Disease: An Identification of Biomarkers for Depiction of Underlying Biological Mechanisms.
Zhang XZ; Zheng SX; Hou YM
Med Sci Monit; 2017 Feb; 23():613-622. PubMed ID: 28151921
[TBL] [Abstract][Full Text] [Related]
49. Alterations of plasma lysophosphatidylcholine species in obesity and weight loss.
Heimerl S; Fischer M; Baessler A; Liebisch G; Sigruener A; Wallner S; Schmitz G
PLoS One; 2014; 9(10):e111348. PubMed ID: 25340546
[TBL] [Abstract][Full Text] [Related]
50. Very long chain acylcarnitines and lysophosphatidylcholines in screening of peroxisomal disease in children by tandem mass spectrometry.
Wang Y; Tian G; Ji W; Wang S; Zhang X
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2021 Aug; 50(4):481-486. PubMed ID: 34704420
[TBL] [Abstract][Full Text] [Related]
51. [Serum lipids in the diagnosis of severity of acute viral hepatitis A].
Makarov VK; Chaĭnikova EA
Klin Lab Diagn; 2006 Oct; (10):18-9. PubMed ID: 17144540
[TBL] [Abstract][Full Text] [Related]
52. Clinical significance of enzymatic lysophosphatidylcholine (LPC) assay data in patients with sepsis.
Cho WH; Park T; Park YY; Huh JW; Lim CM; Koh Y; Song DK; Hong SB
Eur J Clin Microbiol Infect Dis; 2012 Aug; 31(8):1805-10. PubMed ID: 22167258
[TBL] [Abstract][Full Text] [Related]
53. Low plasma lysophosphatidylcholines are associated with impaired mitochondrial oxidative capacity in adults in the Baltimore Longitudinal Study of Aging.
Semba RD; Zhang P; Adelnia F; Sun K; Gonzalez-Freire M; Salem N; Brennan N; Spencer RG; Fishbein K; Khadeer M; Shardell M; Moaddel R; Ferrucci L
Aging Cell; 2019 Apr; 18(2):e12915. PubMed ID: 30719830
[TBL] [Abstract][Full Text] [Related]
54. Lysophosphatidylcholine as a predictor of postoperative complications after colorectal cancer surgery.
Matsuda A; Yamada M; Matsumoto S; Sakurazawa N; Yamada T; Matsutani T; Miyashita M; Uchida E
Surg Today; 2018 Oct; 48(10):936-943. PubMed ID: 29774420
[TBL] [Abstract][Full Text] [Related]
55. The dynamic inflammatory profile of pregnancy can be monitored using a novel lipid-based mass spectrometry technique.
Rees A; Edwards-I-Coll Z; Richards O; Raikes ME; Angelini R; Thornton CA
Mol Omics; 2023 May; 19(4):340-350. PubMed ID: 36883215
[TBL] [Abstract][Full Text] [Related]
56. An enzymatic assay for lysophosphatidylcholine concentration in human serum and plasma.
Kishimoto T; Soda Y; Matsuyama Y; Mizuno K
Clin Biochem; 2002 Jul; 35(5):411-6. PubMed ID: 12270773
[TBL] [Abstract][Full Text] [Related]
57. Increased plasma phosphatidylcholine/lysophosphatidylcholine ratios in patients with Parkinson's disease.
Miletić Vukajlović J; Drakulić D; Pejić S; Ilić TV; Stefanović A; Petković M; Schiller J
Rapid Commun Mass Spectrom; 2020 Feb; 34(4):e8595. PubMed ID: 31519070
[TBL] [Abstract][Full Text] [Related]
58. Lipidomic Profile Revealed the Association of Plasma Lysophosphatidylcholines with Adolescent Obesity.
Wang Y; Jiang CT; Song JY; Song QY; Ma J; Wang HJ
Biomed Res Int; 2019; 2019():1382418. PubMed ID: 31915678
[TBL] [Abstract][Full Text] [Related]
59. Plasma ceramide and lysophosphatidylcholine inversely correlate with mortality in sepsis patients.
Drobnik W; Liebisch G; Audebert FX; Frohlich D; Gluck T; Vogel P; Rothe G; Schmitz G
J Lipid Res; 2003 Apr; 44(4):754-61. PubMed ID: 12562829
[TBL] [Abstract][Full Text] [Related]
60. Interference of lysophosphatidylcholine in hormone radioimmunoassays.
Lepage N; Roberts KD; Langlais J
Clin Chem; 1993 May; 39(5):865-9. PubMed ID: 8485878
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
